FierceBiotech Radio on pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals

FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.

Download the episode on iTunes or Stitcher, or listen below--and be sure to subscribe. Let us know what you think by dropping a line to

This week's episode is sponsored by Catalent.